Sino Biological,Inc. (SHE:301047)
60.43
+0.03 (0.05%)
At close: Apr 30, 2025, 2:57 PM CST
Sino Biological,Inc. Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2017 - 2019 |
Cash & Equivalents | 233.35 | 1,316 | 2,380 | 2,872 | 56.12 | Upgrade
|
Trading Asset Securities | 3,716 | 3,533 | 3,422 | 3,638 | 1,073 | Upgrade
|
Cash & Short-Term Investments | 3,949 | 4,849 | 5,802 | 6,511 | 1,129 | Upgrade
|
Cash Growth | -18.55% | -16.43% | -10.88% | 476.77% | 2067.15% | Upgrade
|
Accounts Receivable | 151.44 | 126.33 | 141.08 | 154.07 | 195.49 | Upgrade
|
Other Receivables | 20.18 | 22.07 | 15.66 | 6.18 | 1.77 | Upgrade
|
Receivables | 171.63 | 148.4 | 156.74 | 160.25 | 197.27 | Upgrade
|
Inventory | 64.4 | 52.53 | 47.49 | 24.75 | 14.25 | Upgrade
|
Prepaid Expenses | 5.45 | 6.63 | - | 6.35 | - | Upgrade
|
Other Current Assets | 16.61 | 12.65 | 17.72 | 16.74 | 18.33 | Upgrade
|
Total Current Assets | 4,208 | 5,069 | 6,024 | 6,719 | 1,359 | Upgrade
|
Property, Plant & Equipment | 893.55 | 900.9 | 210.96 | 107.57 | 52.41 | Upgrade
|
Long-Term Investments | 229.17 | 215.94 | 180.24 | - | - | Upgrade
|
Goodwill | 278.38 | - | - | - | - | Upgrade
|
Other Intangible Assets | 44.79 | 0.8 | 1.11 | 0.92 | 0.38 | Upgrade
|
Long-Term Deferred Tax Assets | 113.81 | 104.63 | 80.28 | 38.26 | 46.56 | Upgrade
|
Long-Term Deferred Charges | 59.69 | 59.73 | 49 | 9.31 | 7.01 | Upgrade
|
Other Long-Term Assets | 227.74 | 249.64 | 34.64 | 15.34 | - | Upgrade
|
Total Assets | 6,055 | 6,601 | 6,580 | 6,890 | 1,465 | Upgrade
|
Accounts Payable | 18.21 | 19.33 | 29.23 | 4.25 | 6.89 | Upgrade
|
Accrued Expenses | 46.04 | 54.3 | 44.09 | 36.02 | 62.08 | Upgrade
|
Current Portion of Leases | 22.47 | 23.37 | 19.81 | 20.45 | - | Upgrade
|
Current Income Taxes Payable | 10.3 | 3.05 | 6.76 | 11.94 | 74.66 | Upgrade
|
Current Unearned Revenue | 29.85 | 22.74 | 20.71 | 13.81 | 9.36 | Upgrade
|
Other Current Liabilities | 70.64 | 13.58 | 4.6 | 11.89 | 7.83 | Upgrade
|
Total Current Liabilities | 197.52 | 136.38 | 125.2 | 98.37 | 160.82 | Upgrade
|
Long-Term Leases | 44.9 | 61.69 | 50.65 | 26.9 | - | Upgrade
|
Long-Term Unearned Revenue | 2.54 | 4.22 | 5.63 | - | - | Upgrade
|
Long-Term Deferred Tax Liabilities | 36.84 | 31.41 | 29.64 | 12.65 | 5.56 | Upgrade
|
Total Liabilities | 281.8 | 233.7 | 211.11 | 137.92 | 166.38 | Upgrade
|
Common Stock | 121.64 | 129.2 | 129.2 | 68 | 51 | Upgrade
|
Additional Paid-In Capital | 4,353 | 4,796 | 4,793 | 4,853 | 141.86 | Upgrade
|
Retained Earnings | 1,300 | 1,434 | 1,432 | 1,809 | 1,089 | Upgrade
|
Comprehensive Income & Other | -1.48 | 7.97 | 14.51 | 22.11 | 16.55 | Upgrade
|
Shareholders' Equity | 5,773 | 6,367 | 6,369 | 6,752 | 1,299 | Upgrade
|
Total Liabilities & Equity | 6,055 | 6,601 | 6,580 | 6,890 | 1,465 | Upgrade
|
Total Debt | 67.37 | 85.06 | 70.46 | 47.36 | - | Upgrade
|
Net Cash (Debt) | 3,882 | 4,764 | 5,732 | 6,463 | 1,129 | Upgrade
|
Net Cash Growth | -18.51% | -16.89% | -11.32% | 472.58% | 2067.15% | Upgrade
|
Net Cash Per Share | 30.34 | 36.87 | 50.32 | 60.03 | 11.65 | Upgrade
|
Filing Date Shares Outstanding | 121.64 | 129.2 | 129.2 | 129.2 | 96.9 | Upgrade
|
Total Common Shares Outstanding | 121.64 | 129.2 | 129.2 | 129.2 | 96.9 | Upgrade
|
Working Capital | 4,010 | 4,933 | 5,899 | 6,620 | 1,198 | Upgrade
|
Book Value Per Share | 47.46 | 49.28 | 49.30 | 52.26 | 13.40 | Upgrade
|
Tangible Book Value | 5,450 | 6,366 | 6,368 | 6,751 | 1,298 | Upgrade
|
Tangible Book Value Per Share | 44.80 | 49.27 | 49.29 | 52.26 | 13.40 | Upgrade
|
Buildings | 637.92 | 637.92 | - | - | - | Upgrade
|
Machinery | 300.85 | 268.29 | 200.86 | 105.49 | 88.17 | Upgrade
|
Construction In Progress | 44.49 | 8.55 | - | - | - | Upgrade
|
Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.